Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06561685

1 development in the corpus

NCT06561685

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · PHASE 1 TRIAL

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

ClinicalTrials.gov

This is a Phase 1 clinical trial registration with no posted results; it is a first-in-human safety and dose-finding study in early stages of recruitment.

PreliminaryEli Lilly and Company LY4050784 Cisplatin

Reported

Planned enrollment340

PhasePhase 1

Study durationup to approximately 4 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support